Albert Korir, the Kenyan distance star who claimed the 2021 New York City Marathon crown, has been hit with a five-year ban from competition after admitting he used a prohibited blood-boosting drug. The decision wipes out his results dating back to early October 2025 and sidelines him through January 2031. It also erases his third-place finish at the 2025 TCS New York City Marathon, marking one of the most serious anti-doping penalties to reach the sport’s top tier in recent months.
AIU decision and penalty
The Athletics Integrity Unit publicly released the first-instance decision last Friday. According to the Athletics Integrity Unit, the tribunal handed Korir five years of ineligibility beginning Jan. 8, 2026, and disqualified all of his results from Oct. 3, 2025. The AIU classifies the matter as “Presence/Use of a Prohibited Substance (CERA)” and notes that the ruling can still be appealed under its disciplinary rules.
What the tests found
Three different samples collected from Korir in October, while he was training for the New York City Marathon, came back positive for continuous erythropoietin receptor activator (CERA), and Korir admitted the violation, according to the Los Angeles Times. The outlet reports that the AIU described the trio of positive tests as “clear evidence” of use on multiple occasions. Korir’s sanction was cut by one year because he accepted the charge and did not seek a hearing, and he will remain barred from competition until January 2031, the Times notes.
What it means for New York's results
Under the AIU decision, Korir’s third-place finish at the Nov. 2, 2025 TCS New York City Marathon is void, along with all of his other results since Oct. 3, 2025, while his 2021 New York City Marathon title stays on the books, according to the AIU listing. The reshuffle changes the official 2025 podium and leaves race organizers and fellow athletes waiting to see whether any appeal could alter the standings yet again.
Broader fallout
Korir’s case is the latest high-profile sanction involving Kenyan distance running at a time when anti-doping authorities are turning up the scrutiny; the country remains under close monitoring even as officials cite progress, the Los Angeles Times reports. The ruling is fueling louder calls for tougher testing and tighter oversight in elite road racing and is prompting renewed debate over how race promoters and national federations can better safeguard clean competitors.
Korir still has the right to appeal the decision through the AIU’s tribunal and appeal stages. For now, the ruling stands as a stark reminder of what is at stake when anti-doping rules are broken and of the ongoing effort to keep performance-enhancing drugs out of the top levels of distance running.
